作者
Victor Mercier,Valérie Letscher-Bru,Marie-Elisabethh Bougnoux,Laurence Delhaès,Françoise Botterel,Danièle Maubon,Frédéric Dalle,Alexandre Alanio,Sandrine Houzé,Éric Dannaoui,Carole Cassagne,Sophie Cassaing,Marie‐Fleur Durieux,Arnaud Fekkar,Jean‐Philippe Bouchara,Jean‐Pierre Gangneux,Julie Bonhomme,Damien Dupont,Damien Costa,Boualem Sendid,Taïeb Chouaki,Nathalie Bourgeois,A Huguenin,Sophie Brun,Caroline Mahinc,Lilia Hasseine,Solène Le Gal,Anne Pauline Bellanger,Éric Bailly,Florent Morio,Céline Nourrisson,Nicole Desbois‐Nogard,E. Perraud-Cateau,Anne Debourgogne,H. Yéra,Laurence Lachaud,Milène Sasso
摘要
Objectives To determine the epidemiological cut-off values (ECVs) of ten antifungal agents in a wide range of yeasts and Aspergillus spp. using gradient concentration strips. Methods The minimum inhibitory concentrations for amphotericin B, anidulafungin, caspofungin, micafungin, flucytosine, fluconazole, itraconazole, isavuconazole, posaconazole, and voriconazole, determined with gradient concentration strips at 35 French microbiology laboratories between 2002 and 2020, were retrospectively collected. Then, the ECVs were calculated using the iterative method and a cut-off value of 97.5%. Results Minimum inhibitory concentrations were available for 17 653 clinical isolates. In total, 48 ECVs (including 32 new ECVs) were determined: 29 ECVs for frequent yeast species (e.g. Candida albicans and itraconazole/flucytosine, and Candida glabrata species complex [SC] and flucytosine) and rare yeast species (e.g. Candida dubliniensis, Candida inconspicua, Saccharomyces cerevisiae, and Cryptococcus neoformans) and 19 ECVs for Aspergillus flavus SC, Aspergillus fumigatus SC, Aspergillus nidulans SC, Aspergillus niger SC, and Aspergillus terreus SC. Conclusions These ECVs can be added to the already available gradient concentration strip–specific ECVs to facilitate minimum inhibitory concentration interpretation and streamline the identification of nonwild type isolates.